Personalized chemotherapy guidance through tumor profiling
Chemobiogram assay is an innovative diagnostic platform that helps personalize chemotherapy for cancer patients. By analyzing how a patient’s tumor responds to different anticancer drugs, the kit helps doctors choose the most effective treatment and predict possible drug resistance.
The kit is currently being tested in research and clinical programs, supporting precision medicine through individualized tumor analysis.
Personalized regimen selection involves resistance profiling to help avoid ineffective treatments. It also uses biopsy-based analysis, utilizing tumor-derived cells for in vitro drug testing. This approach optimizes clinical outcomes by improving treatment success and minimizing unnecessary toxicity.